Summary:
AN ADAPTIVE, PHASE IIB/III, MULTI-CENTER, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF NABEN® (SODIUM BENZOATE), A D-AMINO ACID OXIDASE INHIBITOR, AS AN ADD-ON TREATMENT FOR SCHIZOPHRENIA IN ADULTS
Qualified Participants Must:
• Male or female subjects who are between 18 and 55 years of age
Qualified Participants May Receive:
Compensation for time and travel